When women gained greater control over fertility
When the first contraceptive pill was approved in the United States in 1960, it marked a medical breakthrough. Women could use a highly effective, reversible method without relying on action during every sexual encounter. The ability to decide whether and when to become pregnant mattered far beyond reproductive health: contraception became part of women's opportunities to plan education, employment and family life.
The story was nevertheless more complex than a medicine simply bringing liberation. Early pills contained substantially higher hormone doses than today's products. Trials in places including Puerto Rico during the 1950s have been criticised for inadequate information about risks and side effects and limits on informed consent. Women reported nausea, headaches and other symptoms, yet preventing pregnancy often received more attention than the experiences of participants.
This history illustrates a continuing tension: a medicine can be a major advance while aspects of its safety, development and use deserve criticism. Hormone doses subsequently fell, new progestogens were developed and more methods became available. Knowledge has improved, but individual side effects and how they should be recognised and addressed remain important.
What does contraception do in the body?
All contraceptives share a principal aim: preventing pregnancy. Their mechanisms differ. Most hormonal contraceptives contain a progestogen alone or oestrogen combined with a progestogen. Progestogens are medicines that act on some of the same receptors as the body's progesterone.
Combined pills, patches and vaginal rings contain both oestrogen and a progestogen. They mainly suppress ovulation, so the ovaries generally do not release an egg. They also affect cervical mucus and the uterine lining. The bleeding that often occurs during a hormone-free pill interval is withdrawal bleeding caused by a change in hormone exposure, rather than menstruation following an ovulatory cycle.
Hormonal intrauterine devices (IUDs), implants, injections and progestogen-only pills contain a progestogen. Some, including implants and many pills, suppress ovulation. Other effects include thickening cervical mucus. Hormonal IUDs act largely within the uterus, though some hormone enters the blood, and many users continue to ovulate. Different progestogen methods should therefore be considered separately when discussing effects and side effects.
Copper IUDs contain no hormones: copper creates conditions that impair sperm function and fertilisation. Condoms provide a physical barrier and also reduce sexually transmitted infection risk. Other options include diaphragms, fertility awareness-based methods and sterilisation. Fertility awareness requires understanding fertile days and planning how to avoid unprotected sex during them. Effectiveness varies widely with the method and how it is used.
How effectively does contraception prevent pregnancy?
Comparisons distinguish perfect use from typical use. Perfect use assumes a method is followed exactly; typical use accounts for forgotten pills, incorrectly used condoms and other real-world situations.
Hormonal IUDs, copper IUDs and implants are among the most effective reversible methods: over 99% of users avoid pregnancy in the first year, even with typical use. Pills, patches and rings are highly effective when used correctly but depend more on regular action. Condoms are less effective at pregnancy prevention with typical use, but also help prevent sexually transmitted infections.
The statistically most effective method is not necessarily the best for everyone. Some want hormone-free contraception or infection protection; others prefer long-lasting methods with minimal daily effort. For some, being able to discontinue a method themselves is crucial. Good counselling considers more than pregnancy prevention.
When contraception is also treatment
Contraception has uses beyond preventing pregnancy. Hormonal methods can reduce menstrual bleeding, relieve period pain and make bleeding more predictable, with significant benefits for school, employment, physical activity and quality of life.
Combined pills are also prescribed for acne and certain menstrual symptoms. Hormonal IUDs may reduce heavy bleeding and treat some gynaecological conditions. Hormonal treatment can also help manage endometriosis, a condition in which tissue resembling the uterine lining grows outside the uterus and can cause inflammation and pain. Treatment often aims to reduce bleeding and hormonal changes that contribute to symptoms.
A woman with severe period pain may experience a major improvement even when pregnancy prevention is a lesser priority. Another may find that side effects outweigh benefits. These differences matter in any assessment of contraception.
How serious are the risks?
All medicines require a balance between expected benefit and potential harm. Most people can use a suitable method without serious complications, but risk varies by preparation and by individual health.
Blood clots and oestrogen-containing contraception
Combined hormonal contraception increases the risk of venous blood clots, which form in veins, often in the legs, and can sometimes travel to the lungs. The absolute risk is low but higher than without combined hormonal contraception. European estimates are about two cases annually per 10,000 women who do not use combined methods, compared with approximately five to twelve per 10,000 users, depending on the preparation.
These are population estimates. A person's risk may also depend on previous clots, certain inherited disorders, smoking, age and other medical factors. Risk differs by progestogen type. Norway's Medical Products Agency (DMP) recommends that women choosing combined pills generally select formulations containing levonorgestrel or norgestimate, which are associated with a lower clot risk than some alternatives. DMP highlights implants, hormonal IUDs and oestrogen-free pills as alternatives without the same oestrogen-associated risk.
Breast cancer: what does a small increase in risk mean?
Several large population studies have examined hormonal contraception and breast cancer. A 2023 PLOS Medicine study combined UK records with earlier research and found that current or recent use of combined contraception and several progestogen-only methods was associated with a small relative increase in breast cancer risk.
Absolute risk depended heavily on age. Researchers estimated that five years of oral hormonal contraception would be associated with about eight additional breast cancer cases per 100,000 users starting at 16–20, measured over a 15-year period. Among users starting at 35–39, the estimate was about 265 additional cases per 100,000. Breast cancer is more common as people age. These were observational findings and not all possible confounding factors could be accounted for; the results need context.
Research has also associated combined oral contraception with a lower risk of other cancers, including ovarian and endometrial cancer. The US National Cancer Institute reports that studies of ovarian cancer have found approximately 30–50% lower relative risk among women who have ever used oral contraceptives, depending partly on duration. This does not mean pills should be prescribed to everyone to prevent cancer, but shows why both benefits and risks matter.
What do we know about contraception and mental health?
Some women report low mood, irritability, reduced energy or other emotional changes after starting hormonal contraception. Others describe improved wellbeing as menstrual symptoms diminish or concerns about unintended pregnancy ease. Many notice little change. Researchers have tried to understand these different experiences.
Large observational studies have found links between hormonal contraception and depression diagnoses or antidepressant prescriptions. They can follow very large populations but cannot readily establish causation. Previous mental health, life circumstances, sexual wellbeing and reasons for choosing a method may affect findings.
A 2021 BJPsych Open systematic review and network meta-analysis included twelve randomised trials with 5,833 participants. Random assignment can make causal comparisons more reliable. The analysis found no clear average worsening of depressive symptoms among adult users compared with the examined alternatives. However, the certainty of the evidence was rated very low, and the authors called for more studies of younger women and first-time users.
An absence of an average effect does not rule out symptoms in individuals: improvements for some and deterioration for others can offset each other. Conversely, symptoms appearing after starting contraception can have several causes. Individual follow-up should consider timing, alternative explanations and whether changing or stopping a method is appropriate.
Sex drive, sexuality and quality of life
Hormonal contraception can affect sex-hormone production and metabolism, so researchers have investigated libido, sexual function and satisfaction. Some women report lower desire, dryness or changes in sexual response; others feel freer because they are less concerned about pregnancy. Research is mixed, and experiences differ between methods and individuals.
Relationships, stress, mental health, pain, previous experiences and life circumstances also affect sexuality. It can be difficult to isolate contraception as the cause. Even when causation remains uncertain, a person's experience of a negative change matters to their treatment choice. Counselling should address sexual health and daily comfort, not only pregnancy prevention and rare serious events.
Hormone-free does not mean side-effect-free
Wanting hormone-free contraception may reflect previous experiences, medical circumstances or a preference for a natural hormonal cycle. Effective hormone-free options exist, but the distinction is not simply between methods with and without side effects.
Copper IUDs can cause heavier periods and stronger menstrual pain, which may be particularly problematic for women with heavy bleeding or iron deficiency. Hormonal IUDs may reduce bleeding but frequently cause irregular bleeding at first. Condoms have no hormonal side effects but require correct use during each sexual encounter. Fertility awareness methods can suit some people but require knowledge, monitoring and a plan for fertile days. The right method depends on physical effects, practicality and priorities.
When contraception becomes a question of trust
The history of contraception demonstrates the importance of information about side effects and informed consent. Women's health groups and patient movements have helped draw attention to medicine safety, access to information and the need for alternatives. The history matters when women today describe side effects they feel were inadequately explained.
We should distinguish three questions: has a possible side effect been reported, does research find it more often among users, and has the method been shown to cause it? All three matter. A reported effect with limited research deserves further investigation, while an established side effect can be experienced very differently by individuals. Good advice combines population-level risk estimates with lived experience.
When a method causes distressing symptoms, the conversation should focus on practical next steps: whether treatment can be adjusted, whether another method could suit the person better, and how to prevent pregnancy if they want to stop.
IUD insertion: pain, information and relief
IUD insertion illustrates why medical safety and treatment experience are separate issues. Some women feel mild period-like cramps, while others experience severe pain during or after insertion. Pain may be influenced by previous births, individual factors and how the procedure is performed.
Before insertion, women should be told what will happen, what pain may occur and which pain-relief options are available. They should also be able to ask for the procedure to stop. This applies to initial placement and replacement. A method can be highly effective while the experience of insertion or removal still matters to whether it feels right.
Why does responsibility still fall so heavily on women?
Most highly effective reversible methods have been designed for women's bodies. There are medical reasons for this: ovulation and conditions in the uterus and cervix can be affected through several mechanisms. Yet it also means women often bear the physical burden – medical appointments, medicines, monitoring side effects and procedures to insert or remove IUDs or implants.
Men mainly have condoms and vasectomy, as well as less reliable withdrawal. Vasectomy blocks the tubes that transport sperm and is intended as permanent contraception. Researchers are exploring hormonal and non-hormonal alternatives, including reversible suppression of sperm production or function, but challenges remain around efficacy, safety, reversibility and funding.
In September 2026 the World Health Organization published target product profiles for novel male contraceptive methods, setting out desired characteristics for safe, effective and reversible choices. More options could help share responsibility. Responsibility in relationships also involves participating in decisions, sharing costs, using condoms where appropriate and respecting a partner's wish to change or stop contraception.
When choice also includes the ability to say no
Contraception is often discussed as personal choice, but access to methods does not guarantee a meaningful choice. A woman may want a hormone-free method yet be advised to use hormones for greater pregnancy protection. Another may want an IUD but worry about insertion pain. Some experience side effects while strongly wishing to avoid pregnancy; others may feel pressure from partners, family or clinicians.
Informed choice requires knowledge and the right to decide which physical and practical burdens are acceptable. Healthcare professionals should explain effectiveness, established risks and possible side effects, while making room for individual experiences and priorities. A method can be medically suitable yet feel wrong for its user.
This is particularly relevant for adolescents who may have limited experience of their menstrual cycles. New symptoms may relate to contraception, puberty or other factors. Clear information, accessible follow-up and straightforward ways to seek help are therefore important.
Have we researched what women themselves want to know?
Research provides extensive evidence about pregnancy prevention and a growing understanding of serious effects, including blood clots and associations with some cancers. Questions about quality of life, sexuality and individual responses are harder to answer. Who is most likely to experience low mood or reduced desire with particular preparations? Why does one person benefit from a method another wants to stop? What is the long-term experience of repeatedly switching products?
Different questions require different methods. Randomised trials can investigate causation, large registers can detect rare outcomes over time, and interviews can explain experiences and reasons for changing methods. No single approach provides the entire picture. Research needs to examine daily life as well as clinical safety.
Friend or foe?
Contraception has greatly expanded women's reproductive autonomy and opportunities to plan their lives. Its history also raises questions about drug safety, informed consent and how responsibility is shared between women and men. Hormonal methods can deliver substantial benefits, including pregnancy prevention and treatment of gynaecological symptoms. They can also have documented risks and effects on mood and sexuality that remain complex to study.
A method that improves one woman's quality of life may suit another poorly. Access to contraception is only one part of reproductive autonomy. Understanding treatment, receiving support for side effects and being able to change course are just as important.
Perhaps the central question is not whether contraception is friend or foe, but whether we have developed, studied and organised contraceptive care well enough for women to choose what genuinely works for them.
